Christopher J. Scoggins
Executive Vice President, Diabetes Care
Abbott Laboratories · ABT
$6.6M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 13, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $860K
- Stock Awards
- $1.7M
- Option Awards
- $1.7M
- Incentives
- $1.1M
- Other
- $1.3M
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $859,502 | $1,662,503 | $6,601,667 |
Current Position
- Company
- Abbott Laboratories
- Title
- Executive Vice President, Diabetes Care
- Ticker
- ABT · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 13, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
Accession 0001308179-26-000064.
Other Abbott Executives
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
Abbott · ABT
$24.2M
FY 2025 · DEF 14A
Philip P. Boudreau
Executive Vice President, Finance And Chief Financial Officer
Abbott · ABT
$9.1M
FY 2025 · DEF 14A
Lisa D. Earnhardt
Executive Vice President And Group President, Medical Devices
Abbott · ABT
$8.1M
FY 2025 · DEF 14A
Daniel G. Salvadori
Executive Vice President And Group President, Established Pharmaceuticals And Nutritional Products
Abbott · ABT
$6.5M
FY 2025 · DEF 14A
Hubert L. Allen
Former Executive Vice President, General Counsel And Secretary
Abbott · ABT
$7M
FY 2025 · DEF 14A